These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11425478)

  • 1. Plate-based dormancy culture system for Mycobacterium smegmatis and isolation of metronidazole-resistant mutants.
    Lim A; Dick T
    FEMS Microbiol Lett; 2001 Jun; 200(2):215-9. PubMed ID: 11425478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel metronidazole-inducible genes in Mycobacterium smegmatis using a customized amplification library.
    Kim SY; Shin SJ; Song CH; Jo EK; Kim HJ; Park JK
    FEMS Microbiol Lett; 2008 May; 282(2):282-9. PubMed ID: 18373646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
    Murugasu-Oei B; Dick T
    J Antimicrob Chemother; 2000 Dec; 46(6):917-9. PubMed ID: 11102410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen depletion induced dormancy in Mycobacterium smegmatis.
    Dick T; Lee BH; Murugasu-Oei B
    FEMS Microbiol Lett; 1998 Jun; 163(2):159-64. PubMed ID: 9673018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.
    Lu T; Zhao X; Li X; Hansen G; Blondeau J; Drlica K
    J Antimicrob Chemother; 2003 Jul; 52(1):61-4. PubMed ID: 12805268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a Mycobacterium smegmatis uvrA mutant impaired in dormancy induced by hypoxia and low carbon concentration.
    Cordone A; Audrain B; Calabrese I; Euphrasie D; Reyrat JM
    BMC Microbiol; 2011 Oct; 11():231. PubMed ID: 22008214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel loci associated with mycobacterial isoniazid resistance.
    Viswanathan G; Yadav S; Raghunand TR
    Tuberculosis (Edinb); 2016 Jan; 96():21-6. PubMed ID: 26786650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.
    Wayne LG; Sramek HA
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2054-8. PubMed ID: 7811018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model.
    Khan A; Sarkar D
    Microb Pathog; 2006; 41(2-3):90-5. PubMed ID: 16806798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of a histone-like protein in dormant Mycobacterium smegmatis.
    Lee BH; Murugasu-Oei B; Dick T
    Mol Gen Genet; 1998 Dec; 260(5):475-9. PubMed ID: 9894918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of Mycobacterium smegmatis to stationary phase.
    Smeulders MJ; Keer J; Speight RA; Williams HD
    J Bacteriol; 1999 Jan; 181(1):270-83. PubMed ID: 9864340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis.
    Hutter B; Dick T
    FEMS Microbiol Lett; 1998 Oct; 167(1):7-11. PubMed ID: 9785446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of resistance in Mycobacterium smegmatis.
    Olejníková P; Kurucová M; Švorc L; Marchalín Š
    Can J Microbiol; 2013 Feb; 59(2):126-9. PubMed ID: 23461520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance.
    Springer B; Kidan YG; Prammananan T; Ellrott K; Böttger EC; Sander P
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2877-84. PubMed ID: 11557484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.
    Pruksakorn P; Arai M; Kotoku N; Vilchèze C; Baughn AD; Moodley P; Jacobs WR; Kobayashi M
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3658-63. PubMed ID: 20483615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a diamide sensitive mutant of Mycobacterium smegmatis.
    Rawat M; Heys J; Av-Gay Y
    FEMS Microbiol Lett; 2003 Mar; 220(2):161-9. PubMed ID: 12670676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.